🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Liver Diseases

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test NCT07563309NA3 sites📍 Johannesburg📍 Durban📍 Cape Town bioLytical Laboratories · Tests: TruPlex HIV/HepB/Syphilis Rapid Test Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC NCT06553885Phase 21 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Enfortumab Vedotin Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data NCT07419347n/a2 sites📍 Vancouver📍 Toronto AbbVie Nutritional Assesment in Patients With Cirrhosis NCT05729438n/a1 site📍 Bucharest SUUMC Central Military Hospital Dr Carol Davila · Tests: BCAA Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease NCT07051863n/a1 site📍 Lugano Fondazione Epatocentro Ticino Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence NCT06954116Phase 21 site📍 Wuhan Tongji Hospital · Tests: Iparomlimab and Tuvonralimab (QL1706), Partial hepatectomy Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD) NCT07326592Phase 42 sites📍 Aalborg📍 Vejle CSL Behring · Tests: CE1226 Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD NCT06704321NA1 site📍 Québec Valbiotis · Tests: TOTUM-448, Placebo Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B NCT06680232Phase 17 sites📍 Boston📍 Clichy📍 Hong Kong Precision BioSciences, Inc. · Tests: PBGENE-HBV A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD) NCT07227207Phase 1, Phase 28 sites📍 Jacksonville📍 Boston📍 Rochester Tessera Therapeutics, Inc. · Tests: TSRA-196 Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance NCT06779864n/a1 site📍 Beijing Beijing Friendship Hospital RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study NCT07345247n/a20 sites📍 Adana📍 Adana📍 Adana Ankara University Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement NCT06814990NA1 site📍 Jena Stephanie Gräger · Tests: Cardiac MRI, Blood samples, Echocardiography Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease NCT06607458Phase 220 sites📍 Duarte📍 Santa Monica📍 Miami Delcath Systems Inc. · Tests: Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab, Trifluridine-tipiracil … Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation? NCT06777017n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment NCT06537193NA1 site📍 Seoul Asan Medical Center · Tests: AMRI, CT Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcifications NCT07201649NA1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: a blood test and urine sample collection. Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma NCT06911255Phase 1, Phase 21 site📍 Seoul Yoon Jun Kim · Tests: Tremelimumab Plus Durvalumab (MEDI4736), Transarterial chemoembolization (TACE) Adaptability of an Undetectable = Untransmissible Model for HBV NCT07449091n/a1 site📍 New York NYU Langone Health Advanced Therapies for Liver Metastases NCT04622423n/a1 site📍 Milan IRCCS San Raffaele A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT Global Research Initiative for Patients Screening on MASH NCT05651724n/a13 sites📍 Brussels📍 Antwerp📍 Prague Julius Clinical NAFLD Clinical Care Pathway NCT06671886NA1 site📍 Houston VA Office of Research and Development · Tests: E-trigger The COherence of Scatter Identification and Exclusion Algorithm Study NCT06975579n/a1 site📍 London Institute of Cancer Research, United Kingdom · Tests: Ultrasound image processing Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection NCT06219096NA1 site📍 Chengdu West China Hospital · Tests: NIF image-guided laparoscopic anatomical liver resection with the novel ICG@HSA administration, NIF image-guided laparo… A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) NCT05657873Phase 29 sites📍 Miami📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: L-SABR, Anti-PD-(L)1 based immunotherapy, Platinum based chemotherapy Recurrent Liver Cancer: Reconceptualization and Reevaluation NCT06430983n/a1 site📍 Nanjing Nanjing Medical University Precision Navigation to Improve Community Cancer Screening Participation NCT07676383NA3 sites📍 Huaihua📍 Shaoyang📍 Yongzhou Hunan Cancer Hospital · Tests: Precision Navigation Intervention, Usual Health Education
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy